These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24169533)

  • 1. Aspirin inhibits release of platelet-derived sphingosine-1-phosphate in acute myocardial infarction.
    Polzin A; Rassaf T; Böhm A; Lüth A; Kleuser B; Zeus T; Kelm M; Kroemer HK; Schrör K; Rauch BH
    Int J Cardiol; 2013 Dec; 170(2):e23-4. PubMed ID: 24169533
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose-dependent effect of aspirin on the level of sphingolipids in human blood.
    Knapp M; Lisowska A; Knapp P; Baranowski M
    Adv Med Sci; 2013; 58(2):274-81. PubMed ID: 24101372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation.
    Ulrych T; Böhm A; Polzin A; Daum G; Nüsing RM; Geisslinger G; Hohlfeld T; Schrör K; Rauch BH
    J Thromb Haemost; 2011 Apr; 9(4):790-8. PubMed ID: 21251196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of compliance and dosage adaptation of long term aspirin on platelet function with PFA-100 in patients after myocardial infarction.
    von Pape KW; Strupp G; Bonzel T; Bohner J
    Thromb Haemost; 2005 Oct; 94(4):889-91. PubMed ID: 16270651
    [No Abstract]   [Full Text] [Related]  

  • 6. The membrane expression of P-selectin, but not monocyte-platelet aggregates, is influenced by variability in response to aspirin in patients with coronary artery disease.
    Kuzniatsova N; Shantsila E; Lip GY; Blann AD
    Platelets; 2014; 25(2):142-3. PubMed ID: 23216649
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet hyperfunction is decreased by additional aspirin loading in patients presenting with myocardial infarction on daily aspirin therapy.
    Fuchs I; Spiel AO; Frossard M; Derhaschnig U; Riedmüller E; Jilma B
    Crit Care Med; 2010 Jun; 38(6):1423-9. PubMed ID: 20400900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual cyclooxygenase-1 activity and epinephrine reduce the antiplatelet effect of aspirin in patients with acute myocardial infarction.
    Moscardó A; Santos MT; Fuset MP; Ruano M; Vallés J
    Thromb Haemost; 2011 Apr; 105(4):663-9. PubMed ID: 21301784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction is related to platelet response to aspirin.
    Skoric B; Milicic D; Lovric D; Gornik I; Skoric KN; Sertic J
    Int J Cardiol; 2010 Apr; 140(3):356-8. PubMed ID: 19046612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why an aspirin a day no longer keeps the doctor away ….
    Lordkipanidzé M
    Thromb Haemost; 2011 Feb; 105(2):209-10. PubMed ID: 21136021
    [No Abstract]   [Full Text] [Related]  

  • 11. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
    Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet response to standard aspirin and clopidogrel treatment correlates with long-term outcome in patients with acute ST-elevation myocardial infarction.
    Milicic D; Lovric D; Skoric B; Narancic-Skoric K; Gornik I; Sertic J
    Int J Cardiol; 2011 Dec; 153(2):227-9. PubMed ID: 22000267
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aspirin vs ticlid and their combination in patients with acute myocardial infarction].
    Vyshlov EV; Panfilova EV; Markov VA
    Klin Med (Mosk); 2000; 78(1):37-9. PubMed ID: 10697373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of low dose aspirin on the platelet function in patients with acute myocardial infarction].
    Jin L; Xu SH; Yan XW
    Zhonghua Nei Ke Za Zhi; 1993 Aug; 32(8):542-4. PubMed ID: 8269785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is platelet phospholipid-dependent thrombin generation altered by acute myocardial infarction or aspirin?
    Rota S; Flynn PD; Wareham NJ; Baglin TP; Byrne CD
    Thromb Res; 1996 Aug; 83(4):329-38. PubMed ID: 8870177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tirofiban optimizes platelet inhibition for immediate percutaneous coronary intervention in high-risk acute coronary syndromes.
    Ivandic BT; Kurz K; Keck F; Staritz P; Lehrke S; Katus HA; Giannitsis E
    Thromb Haemost; 2008 Oct; 100(4):648-54. PubMed ID: 18841288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low miR-19b-1-5p expression in isolated platelets after aspirin use is related to aspirin insensitivity.
    Kok MG; Mandolini C; Moerland PD; de Ronde MW; Sondermeijer BM; Halliani A; Nieuwland R; Cipollone F; Creemers EE; Meijers JC; Pinto-Sietsma SJ
    Int J Cardiol; 2016 Jan; 203():262-3. PubMed ID: 26519680
    [No Abstract]   [Full Text] [Related]  

  • 19. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
    Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
    Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial on "Residual platelet reactivity is an independent predictor of myocardial injury in acute myocardial infarction patients on antiaggregant therapy" by Marcucci et al.
    Geisler T; Gawaz M
    Thromb Haemost; 2007 Oct; 98(4):705-6. PubMed ID: 17938789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.